Antoni Martínez-Rubio - Antiarrhythmic Drugs

Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action, the possible adverse effects, and the management of patients prescribed these drugs. The emphasis is on current practice, but with an eye to the near-future direction of treatment. This series of titles will be presented as highly practical information, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The books in the series will provide both an in-depth view of the science and pharmacology behind these drugs and a practical guide to their usage, which is quite unique. Each volume is designed to be between 120 and 250 pages containing practical illustrations and designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas. The books will be priced to attract individuals and presented in a softback format. It will be expected to produce new editions quickly in response to the rapid speed of development of new CV pharmacologic agents.

More information about this series at http://www.springer.com/series/10472

This Springer imprint is published by the registered company Springer Nature Switzerland AG

The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland